{"acute myocardial infarction": 2.11, "alanine aminotransferase increased": 2.17, "amylase increased": 5.16, "aspartate aminotransferase increased": 2.18, "blood alkaline phosphatase increased": 3.37, "blood bilirubin increased": 2.16, "blood cholesterol increased": 4.81, "blood hiv rna increased": 74.28, "blood lactic acid increased": 16.01, "blood triglycerides increased": 6.65, "bursitis": 26.95, "cachexia": 10.54, "cd4 lymphocytes decreased": 36.32, "coeliac disease": 79.5, "constipation": 2.76, "contraindicated product administered": 8.84, "diplopia": 3.74, "drug hypersensitivity": 7.67, "drug interaction": 5.29, "drug intolerance": 6.56, "drug reaction with eosinophilia and systemic symptoms": 3.64, "drug resistance": 14.82, "drug-induced liver injury": 2.39, "dyslipidaemia": 22.74, "exposure during pregnancy": 14.11, "eyelid ptosis": 12.36, "fluid retention": 11.89, "foetal death": 80.43, "foetal exposure during pregnancy": 6.53, "food allergy": 81.43, "gamma-glutamyltransferase increased": 3.16, "hepatic cirrhosis": 4.48, "hepatic enzyme increased": 10.31, "hepatic steatosis": 3.59, "hepatitis c": 2.28, "hepatotoxicity": 2.41, "hiv-associated neurocognitive disorder": 131.19, "hyperbilirubinaemia": 5.45, "hyperhidrosis": 2.07, "hyperlactacidaemia": 52.87, "hyperlipidaemia": 5.43, "hypersensitivity": 4.06, "hypertension": 2.66, "hypertriglyceridaemia": 10.21, "hypophosphataemia": 9.57, "immune reconstitution inflammatory syndrome": 75.53, "immunodeficiency": 58.69, "infection": 3.63, "infusion related reaction": 11.6, "intentional product misuse": 11.12, "jaundice": 3.04, "joint swelling": 5.69, "lactic acidosis": 16.51, "lipoatrophy": 57.2, "lipodystrophy acquired": 99.55, "live birth": 13.14, "maternal exposure during pregnancy": 4.29, "metabolic acidosis": 3.03, "mitochondrial toxicity": 198.08, "multiple-drug resistance": 21.13, "nanasthma": 7082.63, "nephropathy toxic": 6.25, "nervous system disorder": 2.02, "oral candidiasis": 4.04, "osteopenia": 2.03, "overdose": 7.63, "pathogen resistance": 84.08, "pneumocystis jirovecii pneumonia": 3.74, "portal hypertension": 16.17, "premature baby": 2.68, "prescribed overdose": 21.81, "product use issue": 5.31, "progressive external ophthalmoplegia": 2695.81, "progressive multifocal leukoencephalopathy": 11.47, "proteinuria": 3.37, "psoriasis": 6.57, "rash erythematous": 9.83, "renal impairment": 2.47, "rheumatoid arthritis": 6.21, "skin lesion": 2.25, "temperature regulation disorder": 46.24, "thrombocytopenia": 3.57, "transaminases increased": 2.51, "treatment failure": 13.52, "treatment noncompliance": 16.79, "upper respiratory tract infection": 26.13, "viral load increased": 6.21, "viral mutation identified": 163.63, "virologic failure": 97.32}